Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 45.69 USD 3.58% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Omnicell Inc?
Write Note

Omnicell Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Omnicell Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Omnicell Inc
NASDAQ:OMCL
Total Current Liabilities
$961.5m
CAGR 3-Years
42%
CAGR 5-Years
33%
CAGR 10-Years
24%
Veeva Systems Inc
NYSE:VEEV
Total Current Liabilities
$1.1B
CAGR 3-Years
17%
CAGR 5-Years
23%
CAGR 10-Years
26%
Teladoc Health Inc
NYSE:TDOC
Total Current Liabilities
$931.4m
CAGR 3-Years
46%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Total Current Liabilities
$74.3m
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Total Current Liabilities
$147.3m
CAGR 3-Years
13%
CAGR 5-Years
31%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Total Current Liabilities
$123.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Omnicell Inc
Glance View

Market Cap
2.1B USD
Industry
Health Care

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Mountain View, California and currently employs 3,800 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The firm's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The firm's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The firm's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

OMCL Intrinsic Value
44.14 USD
Overvaluation 3%
Intrinsic Value
Price

See Also

What is Omnicell Inc's Total Current Liabilities?
Total Current Liabilities
961.5m USD

Based on the financial report for Sep 30, 2024, Omnicell Inc's Total Current Liabilities amounts to 961.5m USD.

What is Omnicell Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
24%

Over the last year, the Total Current Liabilities growth was 160%. The average annual Total Current Liabilities growth rates for Omnicell Inc have been 42% over the past three years , 33% over the past five years , and 24% over the past ten years .

Back to Top